Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel collaborative agreement to develop Nanotaxi-formulated DNA dengue vaccine

June 21, 2018

Cytokinetics presents data from phase II study of reldesemtiv

June 21, 2018

Luye cleared for phase I trials in China with LY-03012

June 21, 2018

7 Hills Pharma receives support from NIH to develop next-generation integrin activator

June 21, 2018

CStone initiates phase I trial in Australia with MEK inhibitor CS-3006

June 20, 2018

ACY-1215 in combination with nab-paclitaxel shows promising activity in metastatic breast cancer

June 20, 2018

Sarepta reports preliminary data from phase I/IIa gene therapy trial in Duchenne muscular dystrophy

June 20, 2018

IDMC recommends continuation of phase III study of masitinib for metastatic CRPC

June 20, 2018

Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris

June 20, 2018

Clinical benefit noted with NIR-178 in patients with non-small cell lung cancer

June 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...